From seizures to epilepsy and its substrates: Neurocysticercosis

Epilepsia

Volumn 54, Issue 5, 2013, Pages 783-792

  Singh, Gagandeep ^a,b   Burneo, Jorge G ^c   Sander, Josemir W ^a,d,e  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d EPILEPSY SOCIETY   (United Kingdom)

^e STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Calcified cysticercus; Epilepsy; Hippocampal sclerosis; Neurocysticercosis; Seizures

Indexed keywords

ALBENDAZOLE SULFOXIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; PHENYTOIN; PRAZIQUANTEL;

BRAIN; BRAIN CALCIFICATION; BRAIN DEGENERATION; DRUG ANTAGONISM; EPILEPTIC FOCUS; FOLLOW UP; GLIOSIS; HIPPOCAMPAL SCLEROSIS; HUMAN; INTRACTABLE EPILEPSY; MESIAL TEMPORAL LOBE EPILEPSY; NEUROCYSTICERCOSIS; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SEIZURE; SYMPTOMATIC EPILEPSY; TAENIA; TEMPORAL LOBECTOMY;

ANTICONVULSANTS; BRAIN; DEVELOPED COUNTRIES; EPILEPSY; HIPPOCAMPUS; HUMANS; NEUROCYSTICERCOSIS; NEUROIMAGING; RISK FACTORS; SCLEROSIS;

EID: 84876927562     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12159     Document Type: Review

References (74)

1. Agarwal A, Raghav S, Husain M, Kumar R, Gupta RK,. (2004) Epilepsy with focal cerebral calcification: role of magnetization transfer MR imaging. Neurol India 52: 197-199.
2. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC,. (1998) Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 17: 696-700.
3. Baranwal AK, Singhi PD, Singhi SC, Khandelwal N,. (2001) Seizure recurrence in children with focal seizures and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up. J Child Neurol 16: 443-445.
4. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, Tomson T, Hauser WA,. (2010) Recommendation for a definition of acute symptomatic seizure. Epilepsia 51: 671-675.
5. Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, Tsang VC, Gilman RH,. (1999) Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29: 1203-1209.
6. Bianchin MM, Velasco TR, Araujo D Jr, Alexandre V Jr, Wichert-Ana L, Terra-Bustamante VC, Martins Ana Paula P, Santos AC, Walz R, Assirati JAJ, Carlotti CGJ, Takayanagui OM, Sakamoto AC,. (2006a) Clinical and electrophysiological differences between mesial temporal lobe epilepsy and mesial temporal lobe epilepsy plus neurocysticercosis. Epilepsia 47: 244-245.
7. Bianchin MM, Velasco TR, Takayanagui OM, Sakamoto AC,. (2006b) Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored. Lancet Neurol 5: 20-21.
8. Bianchin MM, Velasco TR, Wichert-Ana L, Takayanagui OM, Leite JP, Sakamoto AC,. (2010) How frequent is the association of neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis? Epilepsia 51: 2359-2360.
9. Bittencourt PR, Gracia CM, Martins R, Fernandes AG, Diekmann HW, Jung W,. (1992) Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology 42: 492-496.
10. Burneo JG, Del Brutto O, Delgado-Escueta AV, Gonzalez AE, Medina MT, Montano SM, Moyano LM, Nash T, Roman G, Singh G, White AC Jr, Wiebe S, Garcia HH,. (2009) Workshop report: developing an international collaborative research network in neurocysticercosis and epilepsy. Epilepsia 50: 1289-1290.
11. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M,. (2011) Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.
12. Carpio A, Hauser WA,. (2002) Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 59: 1730-1734.
13. Carpio A, Placencia M, Santillan F, Escobar A,. (1994) A proposal for classification of neurocysticercosis. Can J Neurol Sci 21: 43-47.
14. Carpio A, Escobar A, Hauser WA,. (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39: 1025-1040.
15. Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, Hauser WA,; Ecuadorian Neurocysticercosis G. (2008) Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 79: 1050-1055.
16. Chandra PS, Bal C, Garg A, Gaikwad S, Prasad K, Sharma BS, Sarkar C, Singh MB, Padma VM, Tripathi M,. (2010) Surgery for medically intractable epilepsy due to post infectious etiologies. Epilepsia 51: 1097-1100.
17. Chandy MJ, Rajshekhar V, Ghosh S, Prakash S, Joseph T, Abraham J, Chandi SM,. (1991) Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry 54: 702-705.
18. Chung CK, Lee SK, Chi JG,. (1998) Temporal lobe epilepsy caused by intrahippocampal calcified cysticercus: a case report. J Korean Med Sci 13: 445-448.
19. da Gama CN, Kobayashi E, Li LM, Cendes F,. (2005) Hippocampal atrophy and neurocysticercosis calcifications. Seizure 14: 85-88.
20. de Souza A, Thennarasu K, Yeshraj G, Kovoor JM, Nalini A,. (2009) Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome. J Neurol Sci 276: 108-114.
21. de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K,. (2010) Natural history of solitary cerebral cysticercosis on serial magnetic rsonance imaging and the effect of albendazole therapy on its evolution. J Neurol Sci 288: 135-141.
22. de Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K,. (2011) Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: a prospective study using serial magnetization transfer imaging. Epilepsia 52: 1918-1927.
23. Del Brutto OH,. (1994) Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44: 1706-1709.
24. Del Brutto OH, Garcia HH,. (2012) Neurocysticercosis in nonendemic countries: time for a reappraisal. Neuroepidemiology 39: 145-146.
25. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA,. (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42: 389-392.
26. Del Brutto OH, Santibanez R, Idrovo L, Rodriguez S, Diaz-Calderon E, Navas C, Gilman RH, Cuesta F, Mosquera A, Gonzalez AE, Tsang VC, Garcia HH,. (2005) Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46: 583-587.
27. Del Brutto OH, Roos KL, Coffey CS, Garcia HH,. (2006) Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 145: 43-51.
28. Del Brutto VJ, Del Brutto OH, Ochoa E, Garcia HH,. (2012) Single parenchymal brain cysticercus: relationship between age of patients and evolutive stage of parasites. Neurol Res 34: 967-970.
29. Escobar A, Nieto D,. (1972) Cysticercosis. In, Minkler J, (Ed.) The pathology of nervous system. McGraw-Hill, New York, pp. 2507-2515.
30. Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, Chavarria A, Carrillo Mezo RA, Lloyd C, Dessein A, Preux PM, Dumas M, Larralde C, Sciutto E, Fragoso G,. (2003) High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 22: 139-145.
31. Garcia HH, Del Brutto OH,; Cysticercosis Working Group in P. (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653-661.
32. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, Herrera G, Evans CA, Gonzalez AE,; Cysticercosis Working Group in P. (2004) A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. New Engl J Med 350: 249-258.
33. Garcia HH, Gonzalez I, Mija L,; Cysticercosis Working Group in P. (2007) Neurocysticercosis uncovered by single-dose albendazole. New Engl J Med 356: 1277-1278.
34. Garg RK, Potluri N, Kar AM, Singh MK, Shukla R, Agrawal A, Verma R,. (2006) Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 53: 65-69.
35. Gogia S, Talukdar B, Choudhury V, Arora BS,. (2003) Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 97: 416-421.
36. Gupta M, Agarwal P, Khwaja GA, Chowdhury D, Sharma B, Bansal J, Anand S,. (2002a) Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain. Neurol India 50: 145-147.
37. Gupta RK, Kumar R, Chawla S, Pradhan S,. (2002b) Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 43: 1502-1508.
38. Kalra V, Dua T, Kumar V,. (2003) Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 143: 111-114.
39. Kaushal S, Rani A, Chopra SC, Singh G,. (2006) Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. Neurol India 54: 157-160.
40. Kishore D, Misra S,. (2007) Short course of oral prednisolone on disappearance of lesion and seizure recurrence in patients of solitary cysticercal granuloma with single small enhancing CT lesion: an open label randomized prospective study. J Assoc Physicians India 55: 419-424.
41. Kumar Garg R,. (2003) Risk of seizure recurrence in patients with neurocysticercosis. Natl Med J India 16: 90-91.
42. Lanchote VL, Garcia FS, Dreossi SA, Takayanagui OM,. (2002) Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Ther Drug Monit 24: 338-345.
43. Leite JP, Terra-Bustamante VC, Fernandes RM, Santos AC, Chimelli L, Sakamoto AC, Assirati JA, Takayanagui OM,. (2000) Calcified neurocysticercotic lesions and postsurgery seizure control in temporal lobe epilepsy. Neurology 55: 1485-1491.
44. Liu RS, Lemieux L, Bell GS, Sisodiya SM, Shorvon SD, Sander JW, Duncan JS,. (2003) A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. NeuroImage 20: 22-33.
45. MacArthur WP,. (1934) Cysticercosis as seen in the British army, with special reference to the production of epilepsy. Trans R Soc Trop Med Hyg 27: 343-357.
46. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R,. (2003) Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 44: 1397-1401.
47. Medina MT, Aguilar-Estrada RL, Alvarez A, Duron RM, Martinez L, Dubon S, Estrada AL, Zuniga C, Cartagena D, Thompson A, Ramirez E, Banegas L, Osorio JR, Delgado-Escueta AV, Collins JS, Holden KR,. (2011) Reduction in rate of epilepsy from neurocysticercosis by community interventions: the Salama, Honduras study. Epilepsia 52: 1177-1185.
48. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, Gonzalez AE, Tsang VC, Gilman RH, Garcia HH,; Cysticercosis Working Group in P. (2005) Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65: 229-233.
49. Murthy JM, Subba Reddy YV,. (1998) Prognosis of epilepsy associated with single CT enhancing lesion: a long term follow up study. J Neurol Sci 159: 151-155.
50. Nash TE, Patronas NJ,. (1999) Edema associated with calcified lesions in neurocysticercosis. Neurology 53: 777-781.
51. Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT, Pietsch-Escueta S, Pretell EJ, Takayanagui OM, Theodore W, Tsang VC, Garcia HH,. (2004) Calcific neurocysticercosis and epileptogenesis. Neurology 62: 1934-1938.
52. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH,; Cysticercosis Working Group in P. (2008) Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 1099-1105.
53. Oliveira MC, Castro LH, Martin MG,. (2009) Neurocysticercosis with calcified lesions and mesial temporal sclerosis: fortuitous association or possible etiologic role? Epilepsia 50: 1-502.
54. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, Tsang VC, Pinner RW,; Group EMINS. (2002) Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 8: 608-613.
55. Ooi WW, Wijemanne S, Thomas CB, Quezado M, Brown CR, Nash TE,. (2011) Short report: a calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hygiene 85: 460-463.
56. Otte WM, Singla M, Sander JW, Singh G,. (2013) Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis. Neurology 80: 152-162.
57. Pal DK, Carpio A, Sander JW,. (2000) Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 68: 137-143.
58. Pradhan S, Kathuria MK, Gupta RK,. (2000) Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol 48: 181-187.
59. Prakash S, Garg RK, Kar AM, Shukla R, Agarwal A, Verma R, Singh MK,. (2006) Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: a random evaluation. Seizure 15: 328-332.
60. Quet F, Guerchet M, Pion SD, Ngoungou EB, Nicoletti A, Preux PM,. (2010) Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 51: 830-837.
61. Rajshekhar V,. (2001) Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures. Neurology 57: 2315-2317.
62. Rajshekhar V, Jeyaseelan L,. (2004) Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 62: 2236-2240.
63. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J,. (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67: 2135-2139.
64. Rathore C, Thomas B, Kesavadas C, Radhakrishnan K,. (2012) Calcified neurocysticercosis lesions and hippocampal sclerosis: potential dual pathology? Epilepsia 53: e60-62.
65. Singh G, Sachdev MS, Tirath A, Gupta AK, Avasthi G,. (2000) Focal cortical-subcortical calcifications (FCSCs) and epilepsy in the Indian subcontinent. Epilepsia 41: 718-726.
66. Singh G, Kaushal S, Gupta M, Chander Chopra S,. (2004) Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. J Neurol Neurosurg Psychiatry 75: 331-333.
67. Singh G, Rajshekhar V, Murthy JM, Prabhakar S, Modi M, Khandelwal N, Garcia HH,. (2010) A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 75: 2236-2245.
68. Singh G, Bawa J, Chinna D, Chaudhary A, Saggar K, Modi M, Sander JW,. (2012) Association between epilepsy cysticercosis and toxocariasis: a population-based case-control study in a slum in India. Epilepsia 53: 2203-2208.
69. Singla M, Singh P, Kaushal S, Bansal R, Singh G,. (2007) Hippocampal sclerosis in association with neurocysticercosis. Epileptic Disord 9: 292-299.
70. Sotelo J, Guerrero V, Rubio F,. (1985) Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med 145: 442-445.
71. Thussu A, Arora A, Prabhakar S, Lal V, Sawhney IM,. (2002) Acute symptomatic seizures due to single CT lesions: how long to treat with antiepileptic drugs? Neurol India 50: 141-144.
72. Velasco TR, Zanello PA, Dalmagro CL, Araujo D Jr, Santos AC, Bianchin MM, Alexandre V Jr, Walz R, Assirati JA, Carlotti CG Jr, Takayanagui OM, Sakamoto AC, Leite JP,. (2006) Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients. J Neurol Neurosurg Psychiatry 77: 485-488.
73. Verma A, Misra S,. (2006) Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol Scand 113: 174-177.
74. Wichert-Ana L, Velasco TR, Terra-Bustamante VC, Alexandre V Jr, Walz R, Bianchin MM, Leite JP, Assirati JA, Carlotti CG, Araujo D, Santos AC, Takayanagui OM, Sakamoto AC,. (2004) Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol 61: 1117-1119.